Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system

详细信息    查看全文

• 作者：Bianca D. Lemos ; Barry E. Storer ; Jayasri G. Iyer ; Jerri Linn Phillips ; Christopher K. Bichakjian ; L. Christine Fang ; Timothy M. Johnson ; Nanette J. Liegeois-Kwon ; Clark C. Otley ; Kelly G. Paulson ; Me
• 关键词：clinical staging ; Merkel cell carcinoma ; neuroendocrine carcinoma of the skin ; pathologic staging ; prognosis ; sentinel lymph node biopsy ; staging
• 刊名：Journal of the American Academy of Dermatology
• 出版年：2010
• 出版时间：November 2010
• 年：2010
• 卷：63
• 期：5
• 页码：751-761
• 全文大小：863 K

文摘

Background

The management of Merkel cell carcinoma (MCC) has been complicated by a lack of detailed prognostic data and by the presence of conflicting staging systems.

Objective

We sought to determine the prognostic significance of tumor size, clinical versus pathologic nodal evaluation, and extent of disease at presentation and thereby derive the first consensus staging/prognostic system for MCC.

Methods

A total of 5823 prospectively enrolled MCC cases from the National Cancer Data Base had follow-up data (median 64 months) and were used for prognostic analyses.

Results

At 5 years, overall survival was 40 % and relative survival (compared with age- and sex-matched population data) was 54 % . Among all MCC cases, 66 % presented with local, 27 % with nodal, and 7 % with distant metastatic disease. For cases presenting with local disease only, smaller tumor size was associated with better survival (stage I, ≤2 cm, 66 % relative survival at 5 years; stage II, >2 cm, 51 % ; P < .0001). Patients with clinically local-only disease and pathologically proven negative nodes had better outcome (76 % at 5 years) than those who only underwent clinical nodal evaluation (59 % , P < .0001).

Limitations

The National Cancer Data Base does not capture disease-specific survival. Overall survival for patients with MCC was therefore used to calculate relative survival based on matched population data.

Conclusion

Although the majority (68 % ) of patients with MCC in this nationwide cohort did not undergo pathologic nodal evaluation, this procedure may be indicated in many cases as it improves prognostic accuracy and has important treatment implications for those found to have microscopic nodal involvement.